OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
Derek K. Chu, Alexandro Chu, Daniel Rayner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1493-1519
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

How to Prevent Atopic Dermatitis (Eczema) in 2024: Theory and Evidence
Derek K. Chu, Jennifer J. Koplin, Tasnuva Ahmed, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 7, pp. 1695-1704
Open Access | Times Cited: 11

Topical anti-inflammatory treatments for eczema: network meta-analysis
S. Lax, Eleanor Van Vogt, Bridget Candy, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Closed Access | Times Cited: 7

Efficacy and Safety of Systemic Corticosteroids for Urticaria: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Xiajing Chu, Jason Wang, Leonardo Ologundudu, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 7, pp. 1879-1889.e8
Open Access | Times Cited: 6

Atopic dermatitis - the review
Joanna Wrona, Aleksandra Kaźmierczyk, Jędrzej Kęsik, et al.
Quality in Sport (2025) Vol. 37, pp. 56851-56851
Open Access

Comparison of health-related quality of life in atopic dermatitis, hidradenitis suppurativa, pemphigus and psoriasis
P Balázs, Krisztián Gáspár, Hunor L. Gergely, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access

Challenges in diagnosis and treatment of pediatric psoriasis and atopic dermatitis
Pratiksha Patra, T. G. Harrison, Michael Khoury
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access

Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access

Aspalathin, a key flavonoid in rooibos, restores STAT6-mediated immune dysregulation in atopic dermatitis
In‐Young Yang, Na‐Hee Jeong, Young‐Ae Choi, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117926-117926
Closed Access

Anti-inflammatory agents design via the fragment hybrid strategy in the discovery of compound c1 for treating ALI and UC
Mi Guo, Yu Zou, Ke Dong, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117431-117431
Closed Access

Atopic Dermatitis in Adults: Focus on Topical Therapy
Leisa L. Marshall
The Senior Care Pharmacist (2025) Vol. 40, Iss. 3, pp. 123-134
Closed Access

Management of Infant Atopic Eczema to Prevent Severe Eczema and Food Allergy
Kiwako Yamamoto‐Hanada, Yukihiro Ohya
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 9, pp. 669-681
Closed Access | Times Cited: 4

Atopic Dermatitis (eczema) Guidelines 2023: Highlights
Anna De Benedetto, Mark Boguniewicz, Peck Y. Ong, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2955-2965
Closed Access | Times Cited: 4

Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: a systematic review and meta-analysis of randomized clinical trials
Daniel Rayner, Ming Liu, Alexandro Chu, et al.
Journal of Allergy and Clinical Immunology (2024)
Open Access | Times Cited: 3

Updated Guidelines for Atopic Dermatitis—AAAAI/ACAAI Joint Task Force
Kathryn E. Wheeler, Derek K. Chu, Lynda C. Schneider
JAMA Pediatrics (2024) Vol. 178, Iss. 10, pp. 961-961
Closed Access | Times Cited: 2

Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
Fihr Chaudhary, W. Lee, Tony Escander, et al.
Journal of Biotechnology and Biomedicine (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 2

Topical Anti‐Inflammatory Treatments for Eczema: A Cochrane Systematic Review and Network Meta‐Analysis
S. Lax, Eleanor Van Vogt, Bridget Candy, et al.
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 12, pp. 960-972
Open Access | Times Cited: 2

Assessment of potential predictive factors of dupilumab response in patients with moderate‐to‐severe atopic dermatitis
Gemma Melé‐Ninot, Laia Curto‐Barredo, Montserrat Bonfill‐Ortí, et al.
Australasian Journal of Dermatology (2023) Vol. 65, Iss. 2, pp. 153-162
Open Access | Times Cited: 6

Topical application of Artemisia annua L. essential oil ameliorates 2,4-dintrochlorobenzene-induced atopic dermatitis in mice
Zhian Huang, Bin Fan, Weiwei Mao, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118439-118439
Closed Access | Times Cited: 1

Topical corticosteroids for hives and itch (urticaria): Systematic review and Bayesian meta-analysis of randomized trials
Alexandro Chu, Daniel Rayner, Xiajing Chu, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 4, pp. 437-444.e18
Open Access | Times Cited: 1

Pearls for practice from the 2023 allergy immunology joint task force on practice parameters GRADE and institute of medicine based atopic dermatitis guidelines
Alexandra E. Conway, Navya Kartha, Chaitanya Maddukuri, et al.
Current Opinion in Pediatrics (2024) Vol. 36, Iss. 5, pp. 570-580
Closed Access | Times Cited: 1

Special Considerations in Atopic Dermatitis in Young Children
Mudra Bhatt, Karan Lal, Nanette B. Silverberg
Dermatologic Clinics (2024) Vol. 42, Iss. 4, pp. 611-617
Closed Access | Times Cited: 1

Phosphodiesterase 2 (PDE2) inhibitors: an updated patent review (2017–present)
Bei Zhang, Mei-Yan Jiang, Weihao Luo, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 11, pp. 1105-1119
Closed Access | Times Cited: 1

Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation
M.C.G. Winge, Mazen Nasrallah, Leandra V. Jackrazi, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 777
Closed Access | Times Cited: 1

Atopic dermatitis: Best of guidelines and yardstick
Mark Boguniewicz
Allergy and Asthma Proceedings (2024) Vol. 46, Iss. 1, pp. 19-25
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top